IRF4 regulates IL-17A promoter activity and controls RORγt-dependent Th17 colitis in vivo.
about
Th17 plasticity and its changes associated with inflammatory bowel diseaseRegulation of IL-17 in autoimmune diseases by transcriptional factors and microRNAsIL-17+Foxp3+ T cells: an intermediate differentiation stage between Th17 cells and regulatory T cellsPregnane X receptor as a target for treatment of inflammatory bowel disordersThe development and in vivo function of T helper 9 cellsA genomic regulatory element that directs assembly and function of immune-specific AP-1-IRF complexesIdentification of 15 new psoriasis susceptibility loci highlights the role of innate immunity.Counter-regulation of T cell effector function by differentially activated p38.NOD2 downregulates colonic inflammation by IRF4-mediated inhibition of K63-linked polyubiquitination of RICK and TRAF6.Gene expression profiles in paired gingival biopsies from periodontitis-affected and healthy tissues revealed by massively parallel sequencingDGCR14 induces Il17a gene expression through the RORγ/BAZ1B/RSKS2 complex.The molecular mechanisms of Foxp3 gene regulation.Increased expression of IRF4 and ETS1 in CD4+ cells from patients with intermittent allergic rhinitis.mTOR Inhibition Attenuates Dextran Sulfate Sodium-Induced Colitis by Suppressing T Cell Proliferation and Balancing TH1/TH17/Treg ProfileIL-6 activated integrated BATF/IRF4 functions in lymphocytes are T-bet-independent and reversed by subcutaneous immunotherapyCholera toxin directly enhances IL-17A production from human CD4+ T cells.Ikaros sets the potential for Th17 lineage gene expression through effects on chromatin state in early T cell development.Genome-wide regulatory analysis reveals that T-bet controls Th17 lineage differentiation through direct suppression of IRF4.Interleukin-17A is involved in development of spontaneous pulmonary emphysema caused by Toll-like receptor 4 mutation.IL-22, not simply a Th17 cytokine.Specificity through cooperation: BATF-IRF interactions control immune-regulatory networks.Inhibition of IL-17 as a pharmacological approach for IBD.Th17 cells in immunity and autoimmunity.Tumor necrosis factor α-mediated induction of interleukin 17C in human keratinocytes is controlled by nuclear factor κB.Pathogenic T cell subsets in allergic and chronic inflammatory bowel disorders.Immunopathology alters Th17 cell glucocorticoid sensitivity.Th9 Cells: New Member of T Helper Cell Family.IL-10 Modulates Th17 Pathogenicity during Autoimmune Diseases.Podoplanin is a negative regulator of Th17 inflammationMembers of the novel UBASH3/STS/TULA family of cellular regulators suppress T-cell-driven inflammatory responses in vivo.IL-9 and its receptor are predominantly involved in the pathogenesis of UC.VEGF-C mediated enhancement of lymphatic drainage reduces intestinal inflammation by regulating IL-9/IL-17 balance and improving gut microbiota in experimental chronic colitis.The Th17 Lineage: From Barrier Surfaces Homeostasis to Autoimmunity, Cancer, and HIV-1 Pathogenesis.Opposite effects of interferon regulatory factor 1 and osteopontin on the apoptosis of epithelial cells induced by TNF-α in inflammatory bowel disease.Elevated interferon regulatory factor 4 levels in patients with allergic asthma.Effector T Helper Cell Subsets in Inflammatory Bowel Diseases.Targeting Inflammatory T Helper Cells via Retinoic Acid-Related Orphan Receptor Gamma t Is Ineffective to Prevent Allo-Response-Driven Colitis.
P2860
Q26775934-45BED4DA-C75C-49B5-8938-70F06D5FA229Q26799975-BAA6B7DE-C34C-495A-9AC8-BDA48F74EAD2Q26996213-4B8859E3-72E0-4B50-A8C5-68F2653FA0F3Q26998347-C0D35C76-8D97-4A45-B8D3-8D0BD13792FFQ28083375-1BDB09CD-9B0F-4747-92C1-F9DDDD2C6BB8Q28508859-04F02F8F-5B85-4167-8D6B-24CA9D0BCE91Q30419116-8F3C1C27-9CB0-4EC5-9B7F-FB520356D093Q33702970-3465FC34-258E-4C20-9F2D-FE5D71D49635Q34253078-8F75D52E-2E76-4F6B-9428-0810C628FA15Q34431252-DCC529CB-804F-4AA1-8E18-BCA4AC68C7D9Q35391240-3021A3CF-52C1-483C-8419-7E44E4482DB6Q35490792-76770F36-F91A-4B39-B49D-B350A04FD666Q35613678-00E4F325-40C0-4B31-A588-227B805A01EDQ36003240-757A8581-A8ED-4E9E-9A35-F8F71FC9A778Q36804221-76270572-4A82-4123-B146-F983DE9FBCCCQ37301166-81BCDB06-8C79-41E9-82DB-13CD53A3C54AQ37368649-8EDFE63B-F80A-41DA-B87E-849F386D81D3Q37380878-45B49AB2-CFCF-4E0F-BBA7-C591271C8648Q37728384-E3EB9F8A-444D-4ED5-BDCD-E17DEDB97A1CQ38081171-47846EEE-FB83-4F91-B75A-9993BB0599DCQ38115966-4E36D709-0FB0-4FE4-9C8A-B6F4F62CCB10Q38124101-FBD1A3E0-4B79-4962-9CDD-4EAD862FF53AQ38181087-A28850DC-955D-4DA7-80D3-2FB62C941284Q38334718-C72EA330-A913-43CD-BA16-565ECD010C06Q38665573-D22D0868-CC96-4949-910C-87BF775D9F3FQ38959155-CF6BEF69-1255-48E7-94B1-53F63B740507Q40224209-1185EB48-0575-4F27-8636-01D9979067BEQ41958567-8CD15C9C-5704-49F4-9A32-2A45829E36F1Q42367646-35807556-326D-4012-90D7-E9ECF952E39EQ42673182-BA5B981B-9857-482B-A618-BF77D0128481Q43783161-D1E6A6E2-B2CA-44BA-9F37-B5592E0EA031Q46245598-0B7E6512-5B6F-44AA-86F4-FEFEE75F5272Q47141013-7958E35A-E4C9-49AE-A41E-E8C0049790DAQ54192217-86044563-48EB-4861-ACD6-A0D9D332FA07Q54314051-372C63C1-C2E5-4067-A350-48B8018D416BQ55176161-C1BE1FCD-09CB-4BA9-A774-3F2DAECB407CQ55413412-CB1517E7-D19E-4821-B65E-6FB8DCAE2AAB
P2860
IRF4 regulates IL-17A promoter activity and controls RORγt-dependent Th17 colitis in vivo.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
IRF4 regulates IL-17A promoter ...... ependent Th17 colitis in vivo.
@en
IRF4 regulates IL-17A promoter ...... ependent Th17 colitis in vivo.
@nl
type
label
IRF4 regulates IL-17A promoter ...... ependent Th17 colitis in vivo.
@en
IRF4 regulates IL-17A promoter ...... ependent Th17 colitis in vivo.
@nl
prefLabel
IRF4 regulates IL-17A promoter ...... ependent Th17 colitis in vivo.
@en
IRF4 regulates IL-17A promoter ...... ependent Th17 colitis in vivo.
@nl
P2093
P2860
P50
P356
P1476
IRF4 regulates IL-17A promoter ...... ependent Th17 colitis in vivo.
@en
P2093
Anne Brüstle
Arthur Hoffman
Benno Weigmann
Christel Zufferey
Hans A Lehr
Jingling Yu
Jonas Mudter
Markus F Neurath
Michael Lohoff
Peter R Galle
P2860
P304
P356
10.1002/IBD.21476
P577
2011-02-08T00:00:00Z